RECURSION OS
LIVE

Serial Number

90639127

Owner

RECURSION PHARMACEUTICALS, INC.

Attorney

David Johnson

First Use Date

Aug 29, 2022

Filing Date

Apr 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RECURSION OS Trademark

Serial Number: 90639127 • Registration: 6919234

RECURSION OS is a trademark filed by RECURSION PHARMACEUTICALS, INC. on April 12, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

RECURSION PHARMACEUTICALS, INC. (37 trademarks)

41 SOUTH RIO GRANDE STREET
SALT LAKE CITY, UT 84101

Entity Type: 03

Trademark Details

Filing Date

April 12, 2021

Registration Date

December 6, 2022

First Use Anywhere

August 29, 2022

First Use in Commerce

August 29, 2022

Published for Opposition

January 11, 2022

Goods & Services

Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 2, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 1, 2022 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 23, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Sep 22, 2022 SUPC
SOU EXTENSION 1 GRANTED
Sep 22, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 22, 2022 AITU
USE AMENDMENT FILED
Sep 8, 2022 IUAF
SOU EXTENSION 1 FILED
Sep 8, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 8, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Sep 8, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 8, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 11, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 11, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 8, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 8, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 8, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 8, 2021 CNEA
ASSIGNED TO EXAMINER
Dec 1, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2021 NWOS
NEW APPLICATION ENTERED
Apr 15, 2021 NWAP